Bandingkan Harga & Kinerja Bukit Asam Tbk. (PTBA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bukit Asam Tbk. dan Organon Pharma Indonesia Tbk.: Bukit Asam Tbk. diperdagangkan di Rp3.100 (kapitalisasi pasar 35,71 T, volume 24 jam 51,29 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bukit Asam Tbk. jauh lebih besar — sekitar 342× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PTBA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 35,71 T | 104,4 M |
Volume | 51,29 jt | — |
Lot | 512,91 rb | — |
Perputaran | 158,66 M | — |
Harga Rata-rata | 3.093,33 | — |
Nilai Transaksi | 158,66 M | — |
Harga Ekuilibrium Indikatif | 3.100 | — |
Volume Ekuilibrium Indikatif | 15,39 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bukit Asam Tbk.
PT Bukit Asam (Persero) Tbk was established on March 2nd 1981 in Tanjung Enim as PT. Tambang Batubara Bukit Asam. However the mine working have been exploited since 1919 under Government of Netherland Indie. Take over by Japan on 1942, and nationalized by Indonesian Government on 1945. On October 30th 1990, government merged Perum Tambang Batubara, Sawahlunto in the corporate. On 1983, corporate assigned by government to develop coal briquet. Employees 4021 personnel.
Selengkapnya di halaman PTBA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
